Penumbra Inc (PEN) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally.
Total Assets Chart for Penumbra Inc
Penumbra Inc (PEN) total assets for FY2025 were USD 1.8B, a 19.1% change from FY2024. Penumbra Inc's total assets grew from USD 71.1M in 2013 to USD 1.8B in 2025 (2467.2% over 12 years). Total assets compound annual growth rate: 5-year CAGR of 17.3%, 10-year CAGR of 21.3%.
Total Assets (US Dollars)
R&D as % of Revenue
Key Stats
- Market Cap
- $12.49B
- Implied Share Price
- $317.05
- Enterprise Value
- $12.14B
- Revenue (TTM)
- $1.50B
- EBITDA
- $204.28M
- Profit Margin
- 10.67%
- Trailing P/E
- 77.90
- Forward P/E
- 55.56
- Price/Book (MRQ)
- 8.22
- Price/Sales (TTM)
- 8.30
- EV/EBITDA
- 54.60
- EV/Revenue
- 8.06
- Dividend Yield
- —
- Book Value
- $38.86
- Free Cash Flow (FY2025)
- $174.93M
- Free Cash Flow Yield
- 1.40%
Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.